Investment
Features
FeesSafety
Academy
More
Pluang+

Caledonia Mining beats Q2 earnings estimates with $1.36 EPS, driven by higher gold production and prices.

Company Fundamentals
10 Aug 2026
Stuart Mooney
View Source
Bullish
Caledonia Mining beats Q2 earnings estimates with $1.36 EPS, driven by higher gold production and prices.

Caledonia Mining Corporation Plc reported a strong Q2 2026 earnings per share of $1.36, far exceeding analyst estimates of $0.54. This was driven by an 18% increase in gold production at its Blanket Mine and a 34% rise in the realized gold price, boosting profit after tax by 27% to $30 million. Despite missing revenue estimates, the company’s solid profitability and low debt-to-equity ratio highlight its financial strength. Caledonia also declared a $0.14 quarterly dividend, signaling confidence in ongoing performance.

More News

Berkshire Hathaway poised for growth with $325B T-bills and strong insurance float amid rising rates

Berkshire Hathaway poised for growth with $325B T-bills and strong insurance float amid rising rates

Berkshire Hathaway is well-positioned to benefit from rising interest rates, holding $324.9 billion in Treasury bills that will reprice higher, alongside a $177.5 billion insurance float that funds its growth. Despite concerns about succession, Greg ...

Market News
Bullish
4 hours ago
XRP burn rate spikes 84% despite falling transactions, signaling a key shift in network activity.

XRP burn rate spikes 84% despite falling transactions, signaling a key shift in network activity.

The XRP Ledger's burn rate surged by 84.3%, with 771.7 XRP destroyed as transaction fees, even as transaction and payment volumes declined by around 6-7%. This unusual divergence suggests that the fee cost per transaction has increased significantly,...

Protocol Fundamentals
Neutral
4 hours ago
GH Research gets FDA clearance to start phase 3 trial for new depression treatment in 2026

GH Research gets FDA clearance to start phase 3 trial for new depression treatment in 2026

GH Research PLC has resolved the FDA clinical hold on its investigational new drug (IND) application for GH001, a treatment targeting resistant depression. This clearance allows the company to plan a pivotal phase 3 trial expected to begin in 2026. G...

Analyst Insights
Bullish
4 hours ago
Congressional Black Caucus backs AI regulation with nearly unanimous support for guardrails bill

Congressional Black Caucus backs AI regulation with nearly unanimous support for guardrails bill

The Congressional Black Caucus (CBC) is strongly supporting legislation to regulate artificial intelligence, with nearly all of its 62 members ready to vote in favor of AI guardrails to ensure transparency and safety. CBC leaders emphasize the need t...

Market News
Neutral
4 hours ago
US warns of rapid escalation in Middle East conflict as Iran keeps Strait of Hormuz closed

US warns of rapid escalation in Middle East conflict as Iran keeps Strait of Hormuz closed

The US State Department has urged Americans outside the Middle East to reconsider travel due to the risk of rapid escalation in the Iran conflict. Iran insists the Strait of Hormuz will remain closed until its demands are met, including ending the na...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App